ÂÜÀòÂÒÂ×

Andilyn Mehltretter is a Consultant at Health Advances since May 2021, focusing on portfolio strategy, product launch, lifecycle management, opportunity assessment, corporate development, and commercial diligence for clients in biopharma, high-value diagnostics, and precision medicine. Previously, Andilyn held various roles at Mallinckrodt Pharmaceuticals from January 2020 to April 2021, culminating as Associate Commercial Manager in Oncology, Immunology, and Rare Disease, where efforts were concentrated on commercial initiatives for products in specific clinical areas. Earlier experience includes a consulting position at Michael Page from May 2018 to March 2019. Andilyn holds a Master of Biotechnology in Biopharmaceuticals from the University of Toronto and a Bachelor’s of Science in Pharmacology from McGill University.